New prostate cancer “vaccine” in Phase II trial prior to ADT

According to a media release we saw this morning, a company called Madison Vaccines has started a Phase II clinical trial of a new form of immunotherapy for treatment of men with non-metastatic prostate cancer and rising PSA levels prior to any treatment with androgen deprivation therapy (ADT). … READ MORE …

Potential of metformin in management of recurrent/progressive prostate cancer

A newly published, retrospective, epidemiological study has looked at the potential role of metformin the the management of prostate cancer in > 350 men already diagnosed and being treated for diabetes in the Shared Equal Access Regional Cancer Hospital (SEARCH) database. … READ MORE …

Bad football analogies and prostate cancer news releases

According to a media release issued today by the University of Rochester Medical Center (URMC), “Scientists have identified what may be the Peyton Manning of prostate cancer. It’s a protein that’s essential for the disease to execute its game plan.” … READ MORE …

The ESCAPE project — who gets early metastasis and why?

Researchers at the Department of Urology at Erasmus University Medical Center in Rotterdam appear to have initiated a new — and potentially international — initiative out of findings from the European Randomized Screening Study for Prostate Cancer (ERSCP). The new initiative is known as the ESCAPE project. … READ MORE …

Nitroglycerin for the treatment of progressive prostate cancer?

According to a group of researchers at Queen’s University in Kingston, Ontario, a very low dose of nitroglycerin may be able to delay the progression of prostate cancer in men with a rising PSA after standard first-line treatment with radiotherapy or surgery. … READ MORE …